135 related articles for article (PubMed ID: 38281960)
1. Factors influencing cervical cancer re-screening in a semi-rural health district of Cameroon: a cohort study.
Evina Bolo S; Kenfack B; Wisniak A; Tankeu G; Yakam V; Moukam A; Sormani J; Stoll B; Vassilakos P; Petignat P
BMC Womens Health; 2024 Jan; 24(1):76. PubMed ID: 38281960
[TBL] [Abstract][Full Text] [Related]
2. Recruitment strategies to promote uptake of cervical cancer screening in the West Region of Cameroon.
Pham MA; Benkortbi K; Kenfack B; Tincho Foguem E; Sormani J; Wisniak A; Lemoupa Makajio S; Manga E; Vassilakos P; Petignat P
BMC Public Health; 2022 Mar; 22(1):548. PubMed ID: 35305588
[TBL] [Abstract][Full Text] [Related]
3. "Cervical cancer screening: awareness is not enough". Understanding barriers to screening among women in West Cameroon-a qualitative study using focus groups.
Datchoua Moukam AM; Embolo Owono MS; Kenfack B; Vassilakos P; Petignat P; Sormani J; Schmidt NC
Reprod Health; 2021 Jul; 18(1):147. PubMed ID: 34243778
[TBL] [Abstract][Full Text] [Related]
4. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
5. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
[TBL] [Abstract][Full Text] [Related]
6. Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural Zimbabwe.
Fitzpatrick M; Pathipati MP; McCarty K; Rosenthal A; Katzenstein D; Chirenje ZM; Pinsky B
BMC Womens Health; 2020 Jul; 20(1):153. PubMed ID: 32711530
[TBL] [Abstract][Full Text] [Related]
7. Barriers to cervical cancer prevention in rural Cameroon: a qualitative study on healthcare providers' perspective.
Roux AN; Kenfack B; Ndjalla A; Sormani J; Wisniak A; Tatrai K; Vassilakos P; Petignat P; Schmidt N
BMJ Open; 2021 Jun; 11(6):e043637. PubMed ID: 34140340
[TBL] [Abstract][Full Text] [Related]
8. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of thermocoagulation in a screen-and-treat approach for the treatment of cervical precancerous lesions in sub-Saharan Africa.
Viviano M; Kenfack B; Catarino R; Tincho E; Temogne L; Benski AC; Tebeu PM; Meyer-Hamme U; Vassilakos P; Petignat P
BMC Womens Health; 2017 Jan; 17(1):2. PubMed ID: 28061842
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approach.
Kunckler M; Schumacher F; Kenfack B; Catarino R; Viviano M; Tincho E; Tebeu PM; Temogne L; Vassilakos P; Petignat P
Cancer Med; 2017 Jul; 6(7):1752-1761. PubMed ID: 28580596
[TBL] [Abstract][Full Text] [Related]
11. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
12. Assessing the effectiveness of a community-based sensitization strategy in creating awareness about HPV, cervical cancer and HPV vaccine among parents in North West Cameroon.
Wamai RG; Ayissi CA; Oduwo GO; Perlman S; Welty E; Manga S; Ogembo JG
J Community Health; 2012 Oct; 37(5):917-26. PubMed ID: 22302651
[TBL] [Abstract][Full Text] [Related]
13. Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis.
Gottschlich A; Rivera-Andrade A; Bevilacqua K; Murchland AR; Isak E; Alvarez CS; Ogilvie G; Carey TE; Prince M; Dean M; Mendoza-Montano C; Meza R
BMC Public Health; 2020 Sep; 20(1):1406. PubMed ID: 32933512
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of a community-based cervical cancer screening with "test and treat" strategy using self-sample for an HPV test: Experience from rural Cameroon, Africa.
Fokom Domgue J; Futuh B; Ngalla C; Kakute P; Manjuh F; Manga S; Nulah K; Welty E; Schmeler K; Welty T
Int J Cancer; 2020 Jul; 147(1):128-138. PubMed ID: 31633801
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
16. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
Wong EL; Cheung AW; Wong AY; Chan PK
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
[No Abstract] [Full Text] [Related]
17. Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study.
Mihretie GN; Liyeh TM; Ayele AD; Belay HG; Yimer TS; Miskr AD
Reprod Health; 2022 Jun; 19(1):136. PubMed ID: 35689288
[TBL] [Abstract][Full Text] [Related]
18. A 3-year interval is too short for re-screening women testing negative for human papillomavirus: a population-based cohort study.
Zorzi M; Frayle H; Rizzi M; Fedato C; Rugge M; Penon MG; Bertazzo A; Callegaro S; Campagnolo M; Ortu F; Del Mistro A;
BJOG; 2017 Sep; 124(10):1585-1593. PubMed ID: 28120382
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study).
Orlando G; Tanzi E; Chatenoud L; Gramegna M; Rizzardini G;
BMC Cancer; 2012 May; 12():204. PubMed ID: 22646512
[TBL] [Abstract][Full Text] [Related]
20. Mailing human papillomavirus self-sampling kits to women under-screened for cervical cancer improved detection in cervical cancer screening in a general population study in Japan.
Nishimura Y; Matsuura M; Terada N; Nagao S; Shimada H; Isoyama K; Tamate M; Iwasaki M; Saito T
BMC Public Health; 2023 Mar; 23(1):473. PubMed ID: 36906527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]